John F Crowley is Executive Chairman of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 573,478 shares of FOLD, which is worth approximately $5.61 Million. The most recent transaction as insider was on Sep 01, 2022, when has been sold 11,346 shares (Common Stock) at a price of $11.3 per share, resulting in proceeds of $128,210. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 573K
0% 3M change
37.14% 12M change
Total Value Held $5.61 Million

John F Crowley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 01 2022
SELL
Open market or private sale
$128,210 $11.3 p/Share
11,346 Reduced 1.29%
867,365 Common Stock
Aug 15 2022
SELL
Open market or private sale
$128,547 $12.28 p/Share
10,468 Reduced 1.18%
878,711 Common Stock
Aug 01 2022
SELL
Open market or private sale
$113,006 $9.96 p/Share
11,346 Reduced 1.26%
889,179 Common Stock
Jul 15 2022
SELL
Open market or private sale
$113,682 $10.86 p/Share
10,468 Reduced 1.15%
900,525 Common Stock
Jul 01 2022
SELL
Open market or private sale
$122,310 $10.78 p/Share
11,346 Reduced 1.23%
910,993 Common Stock
Jun 15 2022
SELL
Open market or private sale
$83,849 $8.01 p/Share
10,468 Reduced 1.12%
922,339 Common Stock
Jun 03 2022
SELL
Open market or private sale
$90,768 $8.0 p/Share
11,346 Reduced 1.2%
932,807 Common Stock
May 23 2022
SELL
Open market or private sale
$174,512 $8.0 p/Share
21,814 Reduced 2.26%
944,153 Common Stock
Apr 19 2022
SELL
Open market or private sale
$66,115 $8.01 p/Share
8,254 Reduced 0.85%
965,967 Common Stock
Apr 18 2022
SELL
Open market or private sale
$17,801 $8.04 p/Share
2,214 Reduced 0.23%
974,221 Common Stock
Jan 18 2022
SELL
Open market or private sale
$87,610 $10.23 p/Share
8,564 Reduced 0.87%
976,435 Common Stock
Jan 14 2022
SELL
Payment of exercise price or tax liability
$620,122 $10.53 p/Share
58,891 Reduced 5.64%
984,999 Common Stock
Jan 14 2022
BUY
Grant, award, or other acquisition
-
388,759 Added 27.14%
1,043,890 Common Stock
Jan 05 2022
SELL
Open market or private sale
$773,954 $12.18 p/Share
63,543 Reduced 8.84%
655,131 Common Stock
Jan 04 2022
SELL
Payment of exercise price or tax liability
$141,473 $12.48 p/Share
11,336 Reduced 1.55%
718,674 Common Stock
Jan 03 2022
SELL
Payment of exercise price or tax liability
$485,236 $12.11 p/Share
40,069 Reduced 5.2%
730,010 Common Stock
Jan 02 2022
SELL
Payment of exercise price or tax liability
$265,280 $11.55 p/Share
22,968 Reduced 2.9%
770,079 Common Stock
Dec 31 2021
SELL
Payment of exercise price or tax liability
$363,582 $11.55 p/Share
31,479 Reduced 3.82%
793,047 Common Stock
Nov 15 2021
SELL
Open market or private sale
$292,986 $11.75 p/Share
24,935 Reduced 2.94%
824,526 Common Stock
Nov 15 2021
BUY
Exercise of conversion of derivative security
$109,215 $4.38 p/Share
24,935 Added 2.85%
849,461 Common Stock
Nov 03 2021
SELL
Open market or private sale
$332,868 $12.0 p/Share
27,739 Reduced 3.25%
824,526 Common Stock
Nov 03 2021
BUY
Exercise of conversion of derivative security
$105,963 $3.82 p/Share
27,739 Added 3.15%
852,265 Common Stock
Nov 01 2021
SELL
Open market or private sale
$84,445 $10.8 p/Share
7,819 Reduced 0.94%
824,526 Common Stock
Oct 15 2021
SELL
Open market or private sale
$246,840 $11.22 p/Share
22,000 Reduced 2.58%
832,345 Common Stock
Oct 15 2021
BUY
Exercise of conversion of derivative security
$96,360 $4.38 p/Share
22,000 Added 2.51%
854,345 Common Stock

Also insider at

NTLA
Intellia Therapeutics, Inc. Healthcare
TRDA
Entrada Therapeutics, Inc. Healthcare
JFC

John F Crowley

Executive Chairman
Boston, MA

Track Institutional and Insider Activities on FOLD

Follow AMICUS THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD